Deal of the month: Japan’s Meiji buying Temasek-backed drugmaker Medreich

By Jasleen Kaur Batra

  • 01 Jul 2014
Premium

Deal: Meiji Seika Pharma, a part of Meiji Holdings Co. Ltd, is acquiring Temasek-backed drugmaker Medreich Ltd, a Bangalore-based contract manufacturing pharmaceutical company, for $290 million (Rs 1,720 crore).Target: Started close to four decades ago, Medreich, a fully integrated pharmaceutical company, is involved in the manufacturing and marketing of a ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.